首页> 外国专利> USE OF PEPTIDE FROM CIRCUMSPOROZOITE PROTEIN OF P FALCIPARUM AS UNIVERSALLY RECOGNIZED T-CELL EPITOPE

USE OF PEPTIDE FROM CIRCUMSPOROZOITE PROTEIN OF P FALCIPARUM AS UNIVERSALLY RECOGNIZED T-CELL EPITOPE

机译:恶性疟原虫环孢子蛋白肽作为普遍公认的T细胞表位的用途

摘要

The present invention relates to the use of a peptide from the circumsporozoite (CS) protein of Plasmodium falciparum (P. falciparum) and the derivatives thereof as a universally recognized T-cell epitope i.e. an epitope which is recognized in association with many different human and mouse major histocompatibility complex (MHC) haplotypes e.g. in the context of the human MHC class II molecules such as DR1, DR2, DR4, DR5, DRw6, DR7 or DR9. Furthermore the present invention relates to the above-mentioned peptide per se and to immunogenic compositions comprising such a peptide or a derivative thereof. These immunogenic compositions can be used as vaccines to elicit a durable immune response against a pathogenic agent in humans and animals irrespective of the MHC haplotype of the host.
机译:本发明涉及恶性疟原虫(P.falciparum)的环子孢子(CS)蛋白的肽及其衍生物作为普遍公认的T细胞表位,即与许多不同的人和人类相关联的表位的用途。小鼠主要组织相容性复合体(MHC)单倍型,例如在人类MHC II类分子中,例如DR1,DR2,DR4,DR5,DRw6,DR7或DR9。此外,本发明涉及上述肽本身,并涉及包含该肽或其衍生物的免疫原性组合物。这些免疫原性组合物可用作疫苗,以引发针对人和动物中的病原体的持久免疫应答,而与宿主的MHC单倍型无关。

著录项

  • 公开/公告号GB8812214D0

    专利类型

  • 公开/公告日1988-06-29

    原文格式PDF

  • 申请/专利权人 F HOFFMANN-LA ROCHE & CO AG;

    申请/专利号GB19880012214

  • 发明设计人

    申请日1988-05-24

  • 分类号

  • 国家 GB

  • 入库时间 2022-08-22 06:50:02

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号